We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
R icon
2401
Ryder
R
$10.1B
$644K ﹤0.01%
8,853
+174
+2% +$14K
NKX icon
2402
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
$666M
$643K ﹤0.01%
47,482
-6,812
-13% -$97.5K
BOX icon
2403
Box
BOX
$4.67B
$642K ﹤0.01%
31,234
+18,317
+142% +$394K
AVNT icon
2404
Avient
AVNT
$4.23B
$640K ﹤0.01%
15,045
-46,356
-75% -$2M
SLP icon
2405
Simulations Plus
SLP
$370M
$639K ﹤0.01%
43,348
+26,478
+157% +$423K
HEES
2406
DELISTED
H&E Equipment Services
HEES
$638K ﹤0.01%
16,578
+8,053
+94% +$317K
EDIV icon
2407
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
$635K ﹤0.01%
17,904
-1,710
-9% -$60K
EEFT icon
2408
Euronet Worldwide
EEFT
$2.78B
$635K ﹤0.01%
8,046
+404
+5% +$35.6K
EZM icon
2409
WisdomTree US MidCap Fund
EZM
$960M
$634K ﹤0.01%
16,396
+2,287
+16% +$90.9K
AMPH icon
2410
Amphastar Pharmaceuticals
AMPH
$858M
$633K ﹤0.01%
33,752
+7,989
+31% +$150K
NBR icon
2411
Nabors Industries
NBR
$1.35B
$633K ﹤0.01%
1,810
+25
+1% +$9.11K
THG icon
2412
Hanover Insurance
THG
$7.76B
$628K ﹤0.01%
5,328
-5
-0.1% -$562
CSM icon
2413
ProShares Large Cap Core Plus
CSM
$537M
$627K ﹤0.01%
18,862
+2,000
+12% +$68.3K
PFBC icon
2414
Preferred Bank
PFBC
$1.28B
$627K ﹤0.01%
9,774
+1,066
+12% +$68K
YRD
2415
Yiren Digital
YRD
$106M
$627K ﹤0.01%
15,592
+1,430
+10% +$57.7K
SGI
2416
Somnigroup International
SGI
$13.9B
$627K ﹤0.01%
55,376
+16,872
+44% +$232K
GPP
2417
DELISTED
Green Plains Partners LP
GPP
$627K ﹤0.01%
36,020
+2,485
+7% +$44.4K
ICB
2418
DELISTED
Morgan Stanley Income Sec. Inc
ICB
$627K ﹤0.01%
33,303
+65
+0.2% +$1.22K
AGR
2419
DELISTED
Avangrid, Inc.
AGR
$626K ﹤0.01%
12,244
-5,860
-32% -$286K
HAP icon
2420
VanEck Natural Resources ETF
HAP
$307M
$625K ﹤0.01%
+17,231
New +$643K
PEBK icon
2421
Peoples Bancorp of North Carolina
PEBK
$236M
$624K ﹤0.01%
20,325
RLY icon
2422
State Street Multi-Asset Real Return ETF
RLY
$1.3B
$624K ﹤0.01%
24,041
+102
+0.4% +$2.69K
ETD icon
2423
Ethan Allen Interiors
ETD
$582M
$623K ﹤0.01%
+27,137
New +$684K
PSEC icon
2424
Prospect Capital
PSEC
$1.17B
$622K ﹤0.01%
94,893
+4,237
+5% +$28.3K
WIA
2425
Western Asset Inflation-Linked Income Fund
WIA
$187M
$622K ﹤0.01%
53,954
+13,086
+32% +$153K

Similar funds

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.